Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eli Lilly
Eli Lilly
Lilly backs precision medicine start-up’s $65 million raise
Chemical and Engineering News
Wed, 03/19/25 - 11:16 am
Ampersand Biosciences
Eli Lilly
funding
cancer
Flagship Pioneering
Lilly, J&J, Pfizer and Sanofi back Teva fight against IRA drug negotiation program
Fierce Pharma
Tue, 03/18/25 - 11:00 pm
Teva Pharmaceutical
JNJ
Eli Lilly
Pfizer
Sanofi
legal
Inflation Reduction Act
Lilly, J&J boosted spending on executive security after UnitedHealth shooting
MSN/Reuters
Thu, 03/13/25 - 11:46 am
JNJ
Eli Lilly
executives
UnitedHealth
security
Eli Lilly CEO David Ricks' pay rose to almost $30 million in 2024
Yahoo Finance
Wed, 03/12/25 - 11:27 am
Eli Lilly
Pharma CEOs
David Ricks
executive compensation
Eli Lilly plans launch of weight-loss drug in emerging markets in 2025, CFO says
MSN/Reuters
Mon, 03/10/25 - 11:09 pm
Eli Lilly
Mounjaro
China
India
Mexico
Brazil
emerging markets
Novo counters compounders with direct access channel for Wegovy, price cut for self-paying patients
Fierce Pharma
Wed, 03/5/25 - 11:59 am
Novo Nordisk
DTC
Wegovy
Eli Lilly
weight loss
drug compounding
New tau candidates, including an RNA therapy from Voyager, drive a multi-pronged Alzheimer’s approach
Pharma Voice
Tue, 03/4/25 - 09:51 am
Voyager Therapeutics
RNA
Alzheimer's disease
Eisai
Biogen
Eli Lilly
Where Will Eli Lilly Be in 5 Years?
Motley Fool
Sun, 03/2/25 - 09:41 pm
Eli Lilly
diabetes
obesity
cancer
ulcerative colitis
Lilly hops on hot molecular glue train with $1.6B+ Magnet deal
BioSpace
Fri, 02/28/25 - 11:24 am
Eli Lilly
Magnet Biomedicine
molecular glue
Eli Lilly unveils plan for four U.S. "mega-sites"
Axios
Wed, 02/26/25 - 11:02 am
Eli Lilly
drug manufacturing
reshoring
Organovo’s FXR Program, including FXR314, to Be Acquired by Eli Lilly and Company
Yahoo Finance
Tue, 02/25/25 - 10:38 pm
Organovo
Eli Lilly
FXR agonists
IBD
Eli Lilly is selling higher-dose vials of Zepbound at a lower price to boost weight loss drug access
CNBC
Tue, 02/25/25 - 11:14 am
Eli Lilly
Zepbound
weight loss
LillyDirect
Trump administration, pharma clash: 4 notes
Beckers Hospital Review
Mon, 02/24/25 - 04:54 pm
Donald Trump
tariffs
Eli Lilly
Merck
Pfizer
PhRMA
Eli Lilly, Novo Nordisk lead revenue boom in the 'always tricky' Q4
Fierce Pharma
Mon, 02/24/25 - 11:09 am
earnings
Big Pharma
Eli Lilly
Novo Nordisk
Eli Lilly Bets Big on Weight-Loss Pill With $550 Million Inventory Stockpile
US News and World Report
Thu, 02/20/25 - 06:07 pm
Eli Lilly
weight loss
obesity
clinical trials
orforglipron
Insurers push back on Medicare and Medicaid coverage for GLP-1s
Axios
Thu, 02/20/25 - 11:37 am
insurers
Medicare
Medicaid
obesity
Novo Nordisk
Eli Lilly
Mounjaro
Wegovy
Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO
Pharma Voice
Thu, 02/20/25 - 11:35 am
Immunocore
Travis Coy
Eli Lilly
M&A
Merck, Lilly launch manufacturing R&D consortium to help ‘bolster’ U.S. production
Pharma Voice
Wed, 02/19/25 - 09:44 am
Merck
Eli Lilly
R&D
drug manufacturing
Young Institute Pharmaceutical Manufacturing Consortium
AdvanCell, Lilly partner on new targeted alpha therapies for cancer treatment
Pharmaceutical Business Review
Tue, 02/11/25 - 11:27 am
radiopharmaceuticals
Eli Lilly
AdvanCell
cancer
alpha radiation
Wegovy and Ozempic stars dim amid overuse concerns
Axios
Tue, 02/11/25 - 11:17 am
Wegovy
Ozempic
Zepbound
Mounjaro
Novo Nordisk
Eli Lilly
GLP-1 agonists
obesity
patients
physicians
side effects
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »